Skip to main content
logo
Biocon Limited (NSE:BIOCON)
India flag India · Delayed Price · Currency is INR
396.95
+9.75 (2.52%)
Jul 23, 2025, 3:30 PM IST

Biocon Revenue

In the fiscal year ending March 31, 2025, Biocon had annual revenue of 152.62B INR with 3.43% growth. Biocon had revenue of 44.17B in the quarter ending March 31, 2025, with 12.76% growth.

Revenue
152.62B
Revenue Growth
+3.43%
P/S Ratio
3.47
Revenue / Employee
9.35M
Employees
16,315
Market Cap
529.70B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025152.62B5.06B3.43%
Mar 31, 2024147.56B35.82B32.05%
Mar 31, 2023111.74B29.90B36.54%
Mar 31, 202281.84B10.41B14.57%
Mar 31, 202171.43B8.43B13.37%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries525.78B
Divi's Laboratories93.60B
Cipla272.67B
Mankind Pharma122.07B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Aurobindo Pharma317.24B
Glenmark Pharmaceuticals134.35B
Revenue Rankings

Biocon News

More News